Pelvic Lymph Node Dissection Is Beneficial in Subsets of Patients with Node-positive Melanoma

By Badgwell Brian  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2867-2875

Springer Publishing Company

Access to resources Recommend Favorite

Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model

By Wiener Martin  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 1995-2005

Springer Publishing Company

Access to resources Recommend Favorite

Survival analyses from the ZEBRA study - goserelin (Zoladex(TM)) versus CMF in premenopausal women with node-positive breast cancer

By Kaufmann M.   Jonat W.   Blamey R.   Cuzick J.   Namer M.   Fogelman I.   de Haes J.C.   Schumacher M.   Sauerbrei W.   on behalf of the Zoladex Early Breast Cancer Research Association ZEBRA Trialists' Group  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1711-1717

Elsevier

Access to resources Recommend Favorite

Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer

By Colleoni M.   Price K.   Castiglione-Gertsch M.   Goldhirsch A.   Coates A.   Lindtner J.   Collins J.   Gelber R.D.   Thurlimann B.   Rudenstam C.M.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1693-1700

Elsevier

Access to resources Recommend Favorite

Can Completion Lymph Node Dissection Be Avoided for a Positive Sentinel Node in Melanoma?

By Morton Donald   Scheri Randall   Balch Charles  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2437-2439

Springer Publishing Company

Access to resources Recommend Favorite